Fallahi Mohammad Javad, Pezeshkian Fatemehsadat, Ranjbar Keivan, Javaheri Rojan, Shahriarirad Reza
Department of Internal Medicine Shiraz University of Medical Sciences Shiraz Iran.
Thoracic and Vascular Surgery Research Center Shiraz University of Medical Science Shiraz Iran.
Health Care Sci. 2024 Jun 17;3(3):172-180. doi: 10.1002/hcs2.98. eCollection 2024 Jun.
Silent hypoxemia is when patients do not experience breathing difficulty in the presence of alarmingly low O saturation. It could cause rapid deterioration and higher mortality rates among patients, so prompt detection and identifying predictive factors could result in significantly better outcomes. This study aims to document the evidence of silent hypoxemia in patients with COVID-19 and its clinical features.
A total of 78 hospitalized, nonintubated patients with confirmed COVID-19 infection were included in this study. Their O saturation was measured with a pulse oximeter (PO), and arterial blood gas (ABG) was taken. Demographic and clinical features were recorded. The Borg scale was used to evaluate dyspnea status, and patients with a score of less than two accompanied by O saturation of less than 94% were labeled as silent hypoxic. Univariate analysis was utilized to evaluate the correlation between variables and their odds ratio (OR) and 95% confidence interval (CI).
Silent hypoxemia was observed in 20 (25.6%) of the participants. The average difference between the PO and ABG methods was 4.36 ± 3.43. Based on regression analysis, dyspnea and respiratory rate demonstrated a statistically significant correlation with the O saturation difference between PO and ABG (OR: 2.05; = 0.026; 95% CI: 0.248-3.847 and OR: 0.144; = 0.048, 95% CI: 0.001-0.286). Furthermore, the Borg scale (OR: 0.29; = 0.009; 95% CI: 0.116-0.740) had a significant reverse correlation with silent hypoxia.
Silent hypoxemia can be a possible complication that affects some COVID-19 patients. Further care should be bestowed upon the younger population and those with underlying neurological or mental illnesses. Furthermore, the respiratory rate, pulse oximeter, and arterial blood gas O levels should be considered alongside each other.
静息性低氧血症是指患者在血氧饱和度极低的情况下却没有呼吸困难的症状。它可能导致患者病情迅速恶化并增加死亡率,因此及时检测并识别预测因素可显著改善治疗效果。本研究旨在记录新型冠状病毒肺炎(COVID-19)患者静息性低氧血症的证据及其临床特征。
本研究共纳入78例确诊为COVID-19感染的住院非插管患者。使用脉搏血氧仪(PO)测量他们的血氧饱和度,并采集动脉血气(ABG)。记录人口统计学和临床特征。采用博格量表评估呼吸困难状态,得分低于2分且血氧饱和度低于94%的患者被标记为静息性低氧。采用单因素分析评估变量之间的相关性及其比值比(OR)和95%置信区间(CI)。
20名(25.6%)参与者出现静息性低氧血症。PO和ABG两种方法的平均差异为4.36±3.43。基于回归分析,呼吸困难和呼吸频率与PO和ABG之间的血氧饱和度差异具有统计学显著相关性(OR:2.05;P=0.026;95%CI:0.248-3.847和OR:0.144;P=0.048,95%CI:0.001-0.286)。此外,博格量表(OR:0.29;P=0.009;95%CI:0.116-0.740)与静息性低氧存在显著的负相关。
静息性低氧血症可能是影响部分COVID-19患者的一种并发症。对于年轻人群以及患有潜在神经或精神疾病的患者应给予更多关注。此外,应综合考虑呼吸频率、脉搏血氧仪和动脉血气中的氧水平。